Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

HIP: HIV Intervention for Providers

This study has been completed.
Information provided by (Responsible Party):
Centers for Disease Control and Prevention Identifier:
First received: September 9, 2005
Last updated: September 10, 2012
Last verified: September 2012
The purpose is to encourage Provider participants to evaluate high risk HIV transmission behaviors and offer prevention messages to their HIV+ patients which will, in turn, reduce rates of unprotected anal and/or vaginal sex with partners of known HIV sero-negativity or unknown HIV serostatus. It is hypothesized that patients of providers participating in the HIP intervention will report higher reduction in sexual risk practices, when compared to the patients of the providers who were randomized into the control condition.

Condition Intervention Phase
HIV Infections
Behavioral: HIP: HIV Intervention for Providers
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: HIP: HIV Intervention for Providers

Resource links provided by NLM:

Further study details as provided by Centers for Disease Control and Prevention:

Primary Outcome Measures:
  • Self-reported, unprotected (without condoms) anal or vaginal sex with HIV-negative and unknown-status persons.

Estimated Enrollment: 50
Study Start Date: June 2004
Study Completion Date: September 2008
Primary Completion Date: October 2006 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Provider participants: (1) licensed MD, NP or PA on staff at the participating institution; (2) has a minimum panel of 5 HIV+ patients; (3) sees patients at least one-half day per week in the clinical setting; (4) is willing to participate in all intervention training sessions; and (5) is willing and able to provide full informed consent.

HIV+ patient participants:(1) report at least 1 encounter of unprotected anal or vaginal sex with known HIV- or unknown serostatus partner in the preceding six months; (2) patient's Primary Provider is enrolled as a participant in the study; (3) age 18 years or older; and (4) willing and able to provide informed consent.

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00164398

United States, California
University of California San Francisco - CAPS
San Francisco, California, United States, 94105
Sponsors and Collaborators
Centers for Disease Control and Prevention
Principal Investigator: Dogan Eroglu, PhD. Centers for Disease Control and Prevention
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Centers for Disease Control and Prevention Identifier: NCT00164398     History of Changes
Other Study ID Numbers: CDC-NCHSTP-3986
CCR 920974
Study First Received: September 9, 2005
Last Updated: September 10, 2012

Keywords provided by Centers for Disease Control and Prevention:

Additional relevant MeSH terms:
HIV Infections
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases processed this record on May 23, 2017